BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1585 related articles for article (PubMed ID: 10513726)

  • 1. Leishmaniasis.
    Herwaldt BL
    Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leishmaniasis].
    Kemp M; Theander TG
    Ugeskr Laeger; 2000 Nov; 162(46):6203-7. PubMed ID: 11107967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leishmaniasis. Basic principles, clinical aspects, diagnosis and therapy].
    Burbach G; May J; Harms G; Bienzle U
    Dtsch Med Wochenschr; 1999 Jan; 124(4):88-93. PubMed ID: 10071606
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in leishmaniasis.
    Murray HW; Berman JD; Davies CR; Saravia NG
    Lancet; 2005 Oct 29-Nov 4; 366(9496):1561-77. PubMed ID: 16257344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New World and Old World Leishmania Infections: A Practical Review.
    Kevric I; Cappel MA; Keeling JH
    Dermatol Clin; 2015 Jul; 33(3):579-93. PubMed ID: 26143433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis (kala-azar): challenges ahead.
    Singh RK; Pandey HP; Sundar S
    Indian J Med Res; 2006 Mar; 123(3):331-44. PubMed ID: 16778314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
    Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
    BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives.
    Handler MZ; Patel PA; Kapila R; Al-Qubati Y; Schwartz RA
    J Am Acad Dermatol; 2015 Dec; 73(6):897-908; quiz 909-10. PubMed ID: 26568335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Visceral leishmaniasis in patient with HIV infection].
    Olea P; Pinilla J
    Rev Chilena Infectol; 2013 Apr; 30(2):216-20. PubMed ID: 23677161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).
    Aronson N; Herwaldt BL; Libman M; Pearson R; Lopez-Velez R; Weina P; Carvalho E; Ephros M; Jeronimo S; Magill A
    Am J Trop Med Hyg; 2017 Jan; 96(1):24-45. PubMed ID: 27927991
    [No Abstract]   [Full Text] [Related]  

  • 12. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.
    Calza L; D'Antuono A; Marinacci G; Manfredi R; Colangeli V; Passarini B; Orioli R; Varoli O; Chiodo F
    J Am Acad Dermatol; 2004 Mar; 50(3):461-5. PubMed ID: 14988693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmaniasis in immunosuppressed individuals.
    van Griensven J; Carrillo E; López-Vélez R; Lynen L; Moreno J
    Clin Microbiol Infect; 2014 Apr; 20(4):286-99. PubMed ID: 24450618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmaniasis.
    Piscopo TV; Mallia Azzopardi C
    Postgrad Med J; 2007 Feb; 83(976):649-57. PubMed ID: 17396274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens].
    Aydın Teke T; Metin Timur Ö; Gayretli Aydın ZG; Öz N; Bayhan Gİ; Yılmaz N; Mungan M; Tanır G
    Turkiye Parazitol Derg; 2015 Jun; 39(2):147-50. PubMed ID: 26081889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous and mucocutaneous leishmaniasis.
    David CV; Craft N
    Dermatol Ther; 2009; 22(6):491-502. PubMed ID: 19889134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical mucocutaneous involvement with Leishmania donovani.
    Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S
    Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management.
    Handler MZ; Patel PA; Kapila R; Al-Qubati Y; Schwartz RA
    J Am Acad Dermatol; 2015 Dec; 73(6):911-26; 927-8. PubMed ID: 26568336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and new discoveries in the treatment of leishmaniasis.
    Singh S; Sivakumar R
    J Infect Chemother; 2004 Dec; 10(6):307-15. PubMed ID: 15614453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.